Trafalgar International, Inc. (GCAN): Shareholders' Equity
-$741.6K
As of 2025-12-31
-$12.1K
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$741.6K | n/m | 2026-03-31, Balance as of period end |
| 2024-12-31 | -$840.3K | n/m | 2026-03-31, Balance as of period end |
| 2023-12-31 | -$661.2K | n/m | 2025-05-05, Balance as of period end |
| 2022-12-31 | -$544.8K | n/m | 2024-04-01, Balance as of period end |
| 2021-12-31 | -$469.1K | n/a | 2023-04-13, Balance as of period end |
| 2021-09-30 | -$272.7K | n/a | 2022-04-12, Balance as of period end |
| 2021-06-30 | -$86.5K | n/a | 2022-04-12, Balance as of period end |
| 2021-03-31 | -$348.9K | n/a | 2022-04-12, Balance as of period end |
| 2020-12-31 | -$279.8K | n/a | 2022-04-12, Balance as of period end |
| 2020-09-30 | -$701.3K | n/a | 2022-04-12, Balance as of period end |
| 2020-06-30 | -$1.04M | n/a | 2022-04-12, Balance as of period end |
| 2020-03-31 | -$2.35M | n/a | 2022-04-12, Balance as of period end |
| 2019-12-31 | -$1.55M | n/a | 2021-03-26, Balance as of period end |
| 2019-09-30 | -$639.7K | n/a | 2021-03-26, Balance as of period end |
| 2019-06-30 | -$525.5K | n/a | 2021-03-26, Balance as of period end |
| 2019-03-31 | -$493.6K | n/a | 2021-03-26, Balance as of period end |
| 2018-12-31 | -$563.8K | n/a | 2020-04-14, Balance as of period end |
| 2018-09-30 | -$702.1K | n/a | 2020-04-14, Balance as of period end |
| 2018-06-30 | $100.8K | n/a | 2020-04-14, Balance as of period end |
| 2018-03-31 | $78.5K | n/a | 2020-04-14, Balance as of period end |
| 2017-12-31 | -$390.6K | n/m | 2018-04-26, Balance as of period end |
| 2016-12-31 | -$108.8K | n/m | 2018-04-26, Balance as of period end |
| 2015-12-31 | -$5.8K | n/a | 2018-04-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Trafalgar International, Inc. (GCAN) | 2025-12-31 | -$741.6K | n/m |
| CNBX Pharmaceuticals Inc. (CNBX) | 2025-08-31 | -$2.50M | n/m |
| Nika Pharmaceuticals, Inc (NIKA) | 2025-12-31 | -$297.6K | n/m |
| One World Products, Inc. (OWPC) | 2024-12-31 | -$9.91M | n/m |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | -$10.26M | n/m |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | -$2.13M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
| Cell Source, Inc. (CLCS) | 2024-12-31 | -$18.54M | n/m |
| America Great Health (AAGH) | 2025-06-30 | -$5.66M | n/m |
Compare GCAN, CNBX, NIKA, OWPC side by side · Screen every company in Pharmaceutical Preparations ↗